2023 Q2 Form 10-Q Financial Statement

#000174706823000032 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.0K $705.0K
YoY Change -30.17% 0.71%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $22.51M $19.73M
YoY Change 702.57% 1417.85%
% of Operating Profit
Other Income/Expense, Net $2.874M $2.678M
YoY Change -20.23% -21.9%
Pretax Income $18.61M $21.57M
YoY Change -14.44% -17.12%
Income Tax $5.505M $5.840M
% Of Pretax Income 29.58% 27.07%
Net Earnings $13.11M $15.73M
YoY Change -18.58% -19.04%
Net Earnings / Revenue
Basic Earnings Per Share $0.52 $0.63
Diluted Earnings Per Share $0.51 $0.62
COMMON SHARES
Basic Shares Outstanding 25.14M 25.14M
Diluted Shares Outstanding 25.48M 25.41M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $273.1M $234.5M
YoY Change 16.77% -46.19%
Cash & Equivalents $262.7M $224.1M
Short-Term Investments $10.40M $10.40M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $16.37M $15.17M
YoY Change 27.45% 18.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.475B $3.419B
YoY Change 9.7% 8.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.900M $3.681M
YoY Change 454.77% 1740.5%
Accrued Expenses $8.000M $8.438M
YoY Change -11.42% -10.23%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.90M $12.12M
YoY Change 22.25% 26.24%
LONG-TERM LIABILITIES
Long-Term Debt $400.0K $387.0K
YoY Change 0.25% -3.25%
Other Long-Term Liabilities $66.20M $34.45M
YoY Change 5.68% -42.29%
Total Long-Term Liabilities $66.60M $34.84M
YoY Change 5.65% -42.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.90M $12.12M
Total Long-Term Liabilities $66.60M $34.84M
Total Liabilities $3.102B $3.066B
YoY Change 9.04% 8.27%
SHAREHOLDERS EQUITY
Retained Earnings $301.8M $293.1M
YoY Change 13.26% 15.33%
Common Stock $253.0K $251.0K
YoY Change -0.78% -1.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $373.2M $353.0M
YoY Change
Total Liabilities & Shareholders Equity $3.475B $3.419B
YoY Change 9.7% 8.81%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $13.11M $15.73M
YoY Change -18.58% -19.04%
Depreciation, Depletion And Amortization $500.0K $705.0K
YoY Change -30.17% 0.71%
Cash From Operating Activities $47.20M $25.53M
YoY Change -8.02% -72.96%
INVESTING ACTIVITIES
Capital Expenditures $1.400M $1.162M
YoY Change -512.98% 4369.23%
Acquisitions
YoY Change
Other Investing Activities -$6.900M $48.04M
YoY Change -97.31% -145.23%
Cash From Investing Activities -$8.400M $46.88M
YoY Change -96.73% -144.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K -27.83M
YoY Change -105.25% 485.38%
NET CHANGE
Cash From Operating Activities 47.20M 25.53M
Cash From Investing Activities -8.400M 46.88M
Cash From Financing Activities -200.0K -27.83M
Net Change In Cash 38.60M 44.58M
YoY Change -119.15% -368.39%
FREE CASH FLOW
Cash From Operating Activities $47.20M $25.53M
Capital Expenditures $1.400M $1.162M
Free Cash Flow $45.80M $24.37M
YoY Change -11.34% -74.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2739000
CY2022Q1 mcbs Fees And Commissions And Costs Mortgage Banking And Servicing
FeesAndCommissionsAndCostsMortgageBankingAndServicing
101000
CY2023Q1 mcbs Gain Loss On Sale Of Sba Loans
GainLossOnSaleOfSbaLoans
1969000
CY2022Q1 mcbs Gain Loss On Sale Of Sba Loans
GainLossOnSaleOfSbaLoans
1568000
CY2023Q1 mcbs Sba Servicing Income Net
SbaServicingIncomeNet
1814000
CY2022Q1 mcbs Sba Servicing Income Net
SbaServicingIncomeNet
1644000
CY2023Q1 us-gaap Other Income
OtherIncome
1006000
CY2022Q1 us-gaap Other Income
OtherIncome
492000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
6016000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
7656000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6366000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7096000
CY2023Q1 mcbs Occupancy And Equipment Expense
OccupancyAndEquipmentExpense
1214000
CY2022Q1 mcbs Occupancy And Equipment Expense
OccupancyAndEquipmentExpense
1227000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
275000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
277000
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
146000
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
150000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
2678000
CY2022Q1 us-gaap Other Expenses
OtherExpenses
3429000
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25143675
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001747068
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#InterestReceivable
CY2022Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#InterestReceivable
CY2023Q1 us-gaap Accounts Receivable Noncurrent Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
AccountsReceivableNoncurrentAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#InterestReceivable
CY2022Q4 us-gaap Accounts Receivable Noncurrent Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
AccountsReceivableNoncurrentAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#InterestReceivable
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25169709
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25143675
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
19
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39068
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
METROCITY BANKSHARES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2528408
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5114 Buford Highway
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Doraville
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30340
CY2023Q1 dei City Area Code
CityAreaCode
770
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
455-4989
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
MCBS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
216167000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
150964000
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
7897000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
28521000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224064000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179485000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
10428000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
10300000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
19174000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
19245000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
18947000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
13888000
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2993073000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3041801000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
13642000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
13171000
CY2023Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
17659000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
17493000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15165000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14257000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8030000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8463000
CY2023Q1 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
766000
CY2022Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4328000
CY2023Q1 mcbs Sba Servicing Asset Net
SbaServicingAssetNet
7791000
CY2022Q4 mcbs Sba Servicing Asset Net
SbaServicingAssetNet
7085000
CY2023Q1 mcbs Mortgage Servicing Asset Net
MortgageServicingAssetNet
3205000
CY2022Q4 mcbs Mortgage Servicing Asset Net
MortgageServicingAssetNet
3973000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
69565000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
69130000
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
24008000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
28781000
CY2023Q1 us-gaap Other Assets
OtherAssets
12443000
CY2022Q4 us-gaap Other Assets
OtherAssets
9727000
CY2023Q1 us-gaap Assets
Assets
3419013000
CY2022Q4 us-gaap Assets
Assets
3427239000
CY2023Q1 us-gaap Noninterest Bearing Domestic Deposit Demand
NoninterestBearingDomesticDepositDemand
577282000
CY2022Q4 us-gaap Noninterest Bearing Domestic Deposit Demand
NoninterestBearingDomesticDepositDemand
611991000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2066811000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2054847000
CY2023Q1 us-gaap Deposits
Deposits
2644093000
CY2022Q4 us-gaap Deposits
Deposits
2666838000
CY2023Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
375000000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
375000000
CY2023Q1 us-gaap Other Borrowings
OtherBorrowings
387000
CY2022Q4 us-gaap Other Borrowings
OtherBorrowings
392000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8438000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8885000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3681000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
34453000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
23964000
CY2023Q1 us-gaap Liabilities
Liabilities
3066052000
CY2022Q4 us-gaap Liabilities
Liabilities
3077818000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25143675
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25169709
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
251000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
252000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45044000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45298000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
293139000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
285832000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14527000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18039000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
352961000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
349421000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3419013000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3427239000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
43982000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
31459000
CY2023Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1939000
CY2022Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
492000
CY2023Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
44000
CY2022Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
2000
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
45965000
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
31953000
CY2023Q1 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
17376000
CY2022Q1 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
1139000
CY2023Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
2356000
CY2022Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
161000
CY2023Q1 us-gaap Interest Expense
InterestExpense
19732000
CY2022Q1 us-gaap Interest Expense
InterestExpense
1300000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
26233000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
30653000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
104000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
26233000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
30549000
CY2022Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
1211000
CY2023Q1 mcbs Fees And Commissions And Costs Mortgage Banking And Servicing
FeesAndCommissionsAndCostsMortgageBankingAndServicing
-96000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
10679000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
12179000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21570000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26026000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5840000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6597000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15730000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19429000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15730000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19429000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
368000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1484000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-5134000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
7358000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-1254000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1469000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3512000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4405000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12218000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23834000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
349421000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15730000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
298000
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
553000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3512000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
4558000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
352961000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
290223000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19429000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4405000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3841000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
310410000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
15730000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
19429000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
705000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
711000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
104000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
298000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
194000
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
128000
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-362000
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
547000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
9338000
CY2022Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-15000
CY2022Q1 us-gaap Proceeds From Sale Of Other Loans Held For Sale
ProceedsFromSaleOfOtherLoansHeldForSale
58198000
CY2022Q1 mcbs Gain Loss On Sale Of Residential Mortgages
GainLossOnSaleOfResidentialMortgages
1211000
CY2023Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
36969000
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
23391000
CY2023Q1 mcbs Proceeds From Sales Of Sba Loans Held For Sale
ProceedsFromSalesOfSbaLoansHeldForSale
38938000
CY2022Q1 mcbs Proceeds From Sales Of Sba Loans Held For Sale
ProceedsFromSalesOfSbaLoansHeldForSale
24959000
CY2023Q1 mcbs Gain Loss On Sale Of Sba Loans
GainLossOnSaleOfSbaLoans
1969000
CY2022Q1 mcbs Gain Loss On Sale Of Sba Loans
GainLossOnSaleOfSbaLoans
1568000
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
435000
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
404000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
471000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-408000
CY2023Q1 mcbs Increase Decrease In Sba Servicing Rights
IncreaseDecreaseInSbaServicingRights
706000
CY2022Q1 mcbs Increase Decrease In Sba Servicing Rights
IncreaseDecreaseInSbaServicingRights
320000
CY2023Q1 mcbs Increase Decrease In Mortgage Servicing Rights
IncreaseDecreaseInMortgageServicingRights
768000
CY2022Q1 mcbs Increase Decrease In Mortgage Servicing Rights
IncreaseDecreaseInMortgageServicingRights
822000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
33000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
810000
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
942000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3000
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9410000
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
16915000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25533000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94416000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
421000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
345000
CY2023Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
166000
CY2022Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-3895000
CY2023Q1 mcbs Increase Decrease In Loans Held For Sale For Investing Activities
IncreaseDecreaseInLoansHeldForSaleForInvestingActivities
-43673000
CY2022Q1 mcbs Increase Decrease In Loans Held For Sale For Investing Activities
IncreaseDecreaseInLoansHeldForSaleForInvestingActivities
102527000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1162000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
CY2023Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
4109000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
41000
CY2022Q1 mcbs Payments To Acquire Bank Owned Life Insurance
PaymentsToAcquireBankOwnedLifeInsurance
8000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46875000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-106272000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4526000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3821000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
553000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-22745000
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
119121000
CY2023Q1 us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
5000
CY2022Q1 us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
54000
CY2023Q1 mcbs Proceed From Federal Home Loan Bank Advances
ProceedFromFederalHomeLoanBankAdvances
125000000
CY2023Q1 mcbs Payment For Federal Home Loan Bank Advances
PaymentForFederalHomeLoanBankAdvances
125000000
CY2022Q1 mcbs Payment For Federal Home Loan Bank Advances
PaymentForFederalHomeLoanBankAdvances
120000000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
7786000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27829000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4754000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
44579000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16610000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179485000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
441341000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224064000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424731000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
5337000
CY2022Q1 mcbs Transfer Of Loan Principal To Loans Held For Sale
TransferOfLoanPrincipalToLoansHeldForSale
94915000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
18790000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1297000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
686000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
488000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
79000
CY2022Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
114000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
22281000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3107000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
19174000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
22720000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3475000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
19245000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5697000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5676000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
379000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
375000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
6867000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
22281000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
19174000
CY2023Q1 mcbs Fair Value Of Securities Pledged
FairValueOfSecuritiesPledged
14300000
CY2022Q4 mcbs Number Of Securities Pledged
NumberOfSecuritiesPledged
0
CY2022Q1 mcbs Number Of Securities Sold
NumberOfSecuritiesSold
0
CY2023Q1 mcbs Number Of Securities Sold
NumberOfSecuritiesSold
0
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3107000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
14340000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
804000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
4097000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2671000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
10089000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
19
CY2023Q1 mcbs Debt Securities Available For Sale Percentage Of Depreciation
DebtSecuritiesAvailableForSalePercentageOfDepreciation
0.1781
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
10400000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
10300000
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
128000
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-362000
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3021320000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3065329000
CY2023Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
9300000
CY2022Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
9640000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
18947000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
13888000
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2993073000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3041801000
CY2023Q1 us-gaap Accounts Receivable Noncurrent Accrued Interest After Allowance For Credit Loss
AccountsReceivableNoncurrentAccruedInterestAfterAllowanceForCreditLoss
13600000
CY2022Q4 us-gaap Accounts Receivable Noncurrent Accrued Interest After Allowance For Credit Loss
AccountsReceivableNoncurrentAccruedInterestAfterAllowanceForCreditLoss
13100000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
13888000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
4000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
18947000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
16952000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-390000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
8000
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
104000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Revolving
FinancingReceivableExcludingAccruedInterestRevolving
12524000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
3012020000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Revolving Converted To Term Loan
FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan
0
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
3055689000
CY2023Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2023Q1 us-gaap Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
0
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
16674000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
714000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
13174000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
13888000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
29926000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3025763000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
3055689000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
29926000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
28313000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
2412000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
30725000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
714000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
9064000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
3012020000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
10065000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
3055689000
CY2023Q1 mcbs Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
1321000
CY2023Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
7743000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
9064000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
66881000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
1018059000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
1040541000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
412276000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
155666000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
306073000
CY2023Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
6900000
CY2022Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
7200000
CY2023Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
375000000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
375000000
CY2023Q1 mcbs Advances From Federal Home Loan Banks Call Amounts Every Nine Months
AdvancesFromFederalHomeLoanBanksCallAmountsEveryNineMonths
100000000.0
CY2023Q1 mcbs Advances From Federal Home Loan Banks Call Amounts Every Twelve Months
AdvancesFromFederalHomeLoanBanksCallAmountsEveryTwelveMonths
275000000.0
CY2023Q1 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
1030000000.00
CY2022Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
1010000000.00
CY2023Q1 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
2270000000
CY2022Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
2290000000
CY2023Q1 us-gaap Secured Debt
SecuredDebt
387000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
392000
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
false
CY2023Q1 mcbs Lessee Operating Lease Number Of Short Term Leases
LesseeOperatingLeaseNumberOfShortTermLeases
0
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
541000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
505000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
44000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
44000
CY2023Q1 us-gaap Lease Cost
LeaseCost
585000
CY2022Q1 us-gaap Lease Cost
LeaseCost
549000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
2002000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
1858000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
1597000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
1358000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
1079000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
1302000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9196000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
758000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8438000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0318
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
513000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
487000
CY2023Q1 mcbs Operating Lease Liability Reduction Payments
OperatingLeaseLiabilityReductionPayments
447000
CY2022Q1 mcbs Operating Lease Liability Reduction Payments
OperatingLeaseLiabilityReductionPayments
416000
CY2022Q1 mcbs Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Securities Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisSecuritiesGainLossIncludedInEarnings
0
CY2023Q1 mcbs Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Securities Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisSecuritiesGainLossIncludedInEarnings
0
CY2022Q1 mcbs Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Purchases Sales Or Transfers Ne
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisPurchasesSalesOrTransfersNe
0
CY2023Q1 mcbs Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Purchases Sales Or Transfers Ne
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisPurchasesSalesOrTransfersNe
0
CY2021 mcbs Capital Conservation Buffer Percentage
CapitalConservationBufferPercentage
0.0250
CY2023Q1 us-gaap Capital
Capital
349829000
CY2023Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1751
CY2023Q1 mcbs Capital Required For Capital Adequacy Including Buffer
CapitalRequiredForCapitalAdequacyIncludingBuffer
209801000
CY2023Q1 mcbs Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
CapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.105
CY2023Q1 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
330643000
CY2023Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1655
CY2023Q1 mcbs Tier One Risk Based Capital Required For Capital Adequacy Including Buffer
TierOneRiskBasedCapitalRequiredForCapitalAdequacyIncludingBuffer
169839000
CY2023Q1 mcbs Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.085
CY2023Q1 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
330643000
CY2023Q1 mcbs Common Equity Tier One Capital To Risk Weighted Assets
CommonEquityTierOneCapitalToRiskWeightedAssets
0.1655
CY2023Q1 mcbs Common Equity Tier One Capital Required For Capital Adequacy Including Buffer
CommonEquityTierOneCapitalRequiredForCapitalAdequacyIncludingBuffer
139867000
CY2023Q1 mcbs Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.070
CY2023Q1 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
330643000
CY2023Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0972
CY2023Q1 mcbs Tier One Leverage Capital Required For Capital Adequacy Including Buffer
TierOneLeverageCapitalRequiredForCapitalAdequacyIncludingBuffer
136114000
CY2023Q1 mcbs Tier One Leverage Capital Required For Capital Adequacy To Average Assets Including Buffer
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssetsIncludingBuffer
0.040
CY2022Q4 us-gaap Capital
Capital
338185000
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1668
CY2022Q4 mcbs Capital Required For Capital Adequacy Including Buffer
CapitalRequiredForCapitalAdequacyIncludingBuffer
212932000
CY2022Q4 mcbs Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
CapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.105
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
324297000
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1599
CY2022Q4 mcbs Tier One Risk Based Capital Required For Capital Adequacy Including Buffer
TierOneRiskBasedCapitalRequiredForCapitalAdequacyIncludingBuffer
172374000
CY2022Q4 mcbs Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.085
CY2022Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
324297000
CY2022Q4 mcbs Common Equity Tier One Capital To Risk Weighted Assets
CommonEquityTierOneCapitalToRiskWeightedAssets
0.1599
CY2022Q4 mcbs Common Equity Tier One Capital Required For Capital Adequacy Including Buffer
CommonEquityTierOneCapitalRequiredForCapitalAdequacyIncludingBuffer
141955000
CY2022Q4 mcbs Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets Including Buffer
CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssetsIncludingBuffer
0.070
CY2022Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
324297000
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0957
CY2022Q4 mcbs Tier One Leverage Capital Required For Capital Adequacy Including Buffer
TierOneLeverageCapitalRequiredForCapitalAdequacyIncludingBuffer
135485000
CY2022Q4 mcbs Tier One Leverage Capital Required For Capital Adequacy To Average Assets Including Buffer
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssetsIncludingBuffer
0.040
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15730000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19429000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25144683
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25465236
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15730000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19429000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25144683
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25465236
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
261172
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
253799
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25405855
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25719035
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001747068-23-000032-index-headers.html Edgar Link pending
0001747068-23-000032-index.html Edgar Link pending
0001747068-23-000032.txt Edgar Link pending
0001747068-23-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mcbs-20230331.xsd Edgar Link pending
mcbs-20230331x10q.htm Edgar Link pending
mcbs-20230331xex31d1.htm Edgar Link pending
mcbs-20230331xex31d2.htm Edgar Link pending
mcbs-20230331xex32d1.htm Edgar Link pending
mcbs-20230331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
mcbs-20230331_cal.xml Edgar Link unprocessable
mcbs-20230331_def.xml Edgar Link unprocessable
mcbs-20230331_lab.xml Edgar Link unprocessable
mcbs-20230331_pre.xml Edgar Link unprocessable
mcbs-20230331x10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending